M. Ruston

Lasers in the treatment of bladder cancer.

C. Fowler, M. Ruston, Miranda A. Ruston, 1991, British journal of urology.

Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.

K. Biggadike, D. Holmes, P. Procopiou, 2014, Journal of medicinal chemistry.

The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.

R. Perciaccante, Valerie S. Morrison, P. Procopiou, 2011, Bioorganic & medicinal chemistry.

Benign intraepithelial cysts of the parietal layer of tunica vaginalis of the testis.

R. Morgan, F. Mumtaz, M. Ruston, 1996, British journal of urology.

Selectivity ofmeso-tetra(hydroxyphenyl)porphyrins and chlorins and of photofrin II in causing photodamage in tumour, skin, muscle and bladder. The comcept of cost-benefit in analysing the results

R. Bonnett, M. Berenbaum, E. Chevretton, 1993, Lasers in Medical Science.

Ruptured bladder following a phosphate enema.

M. Ruston, F. Smedley, M. Taube, 1988, British Journal of Urology.

Malignant change in perianal condylomata acuminata.

M. Ruston, F. Smedley, M. Taube, 1988, Journal of the Royal College of Surgeons of Edinburgh.